Publication: T cell–derived interleukin (IL)-21 promotes brain injury following stroke in mice
Open/View Files
Date
2014
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Rockefeller University Press
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Clarkson, B. D., C. Ling, Y. Shi, M. G. Harris, A. Rayasam, D. Sun, M. S. Salamat, et al. 2014. “T cell–derived interleukin (IL)-21 promotes brain injury following stroke in mice.” The Journal of Experimental Medicine 211 (4): 595-604. doi:10.1084/jem.20131377. http://dx.doi.org/10.1084/jem.20131377.
Research Data
Abstract
T lymphocytes are key contributors to the acute phase of cerebral ischemia reperfusion injury, but the relevant T cell–derived mediators of tissue injury remain unknown. Using a mouse model of transient focal brain ischemia, we report that IL-21 is highly up-regulated in the injured mouse brain after cerebral ischemia. IL-21–deficient mice have smaller infarcts, improved neurological function, and reduced lymphocyte accumulation in the brain within 24 h of reperfusion. Intracellular cytokine staining and adoptive transfer experiments revealed that brain-infiltrating CD4+ T cells are the predominant IL-21 source. Mice treated with decoy IL-21 receptor Fc fusion protein are protected from reperfusion injury. In postmortem human brain tissue, IL-21 localized to perivascular CD4+ T cells in the area surrounding acute stroke lesions, suggesting that IL-21–mediated brain injury may be relevant to human stroke.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service